Issar Pharmaceuticals Private Limited, a converted to llp private limited company, was established on 31 October 1995 in Hyderabad, Telangana, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24239TG1995PTC022131. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹55.00 Cr and a paid-up capital of ₹55.00 Cr.
It upholds a compliant status. Its leadership includes Rama Krishna Reddy Isanaka (Director), Isanaka Shaalini (Director). Past directors included Sheila Isanaka, Vijay Krishna Akepati, Tatavarthy Satyanarayana Murthy. It holds no open charges and ₹28.25 Cr settled loans. Its latest AGM occurred on 30 September 2022, with the balance sheet filed on 31 March 2022. It is based at H. No. 8-2-334, Serene Chambers, Flat No. W - 301 & 302, Road No.5, Banja, Ra Hills, Hyderabad, Telangana, 500034.
U24239TG1995PTC022131
022131
31 October 1995
₹55.00 Cr
₹55.00 Cr
Roc Hyderabad
Unlisted
Converted to LLP
Explore comprehensive insights into Issar Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Rama Krishna Reddy Isanaka | Director | 02 Sep 1999 | Current |
| Isanaka Shaalini | Director | 12 Apr 2016 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 01 Oct 2022 | Past |
| Pramod Abcsdd | Director | 01 Nov 2011 | Past |
| Pramod Abcsdd | Additional Director | 25 Jul 2022 | Past |
| Pramod Abcsdd | Director | 26 Nov 2015 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2016 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2016 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Issar Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 98.03% decrease. The company also saw a substantial fall in profitability, with a 105.85% decrease in profit. The company's net worth dipped by a decrease of 0.71%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2022, Issar Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹0
₹282,530,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 16 Jun 2011 | State Bank Of India | ₹24.20 Cr | Satisfied |
| 05 Jun 2006 | Uti Bank Limited | ₹1.00 Cr | Satisfied |
| 12 Nov 2005 | The Karnataka Bank Limited | ₹2.50 M | Satisfied |
| 12 Nov 2005 | The Karnataka Bank Limited | ₹0.00 | Satisfied |
| 19 Nov 2003 | Karnataka Bank | ₹0.53 M | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Issar Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Issar Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Issar Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Issar Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2022 as per latest MCA records. was documented.
The activity Issar Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2022 with Roc Hyderabad. was completed.
A charge registered on 16 Jun 2011 via Charge ID 10294014 with State Bank Of India was fully satisfied on 17 Jun 2016. was recorded as a recent event.
The activity Isanaka Shaalini was appointed as a Director was appointed as a Director on 12 Apr 2016 & has been associated with this company since 9 years 7 months . was completed.
Progress on A charge with State Bank Of India amounted to Rs. 24.20 Cr with Charge ID 10294014 was registered on 16 Jun 2011. was documented.
A charge registered on 05 Jun 2006 via Charge ID 10006700 with Uti Bank Limited was fully satisfied on 07 Jun 2011. was recorded as a recent event.
Melgain will be marketed in India by Liva Healthcare, a specialty division of Zydus group catering to the dermatological segment.
The CIN of Issar Pharmaceuticals Private Limited is U24239TG1995PTC022131.
Issar Pharmaceuticals Private Limited is headquartered at H. No. 8-2-334, Serene Chambers, Flat No. W - 301 & 302, Road No.5, Banja, Ra Hills, Hyderabad, Telangana, 500034.
Issar Pharmaceuticals Private Limited was incorporated on 31 October 1995.
The current directors of Issar Pharmaceuticals Private Limited are
The primary industry of Issar Pharmaceuticals Private Limited is Manufacturing.
Issar Pharmaceuticals Private Limited is unlisted.
The authorized capital of Issar Pharmaceuticals Private Limited is ₹55.00 Cr, and the paid-up capital is ₹55.00 Cr.
The compliance status of Issar Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX